Search for: "Amgen Inc" Results 81 - 100 of 698
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Oct 2022, 6:30 am
Posted by Laura Harder, Cleary Gottlieb Steen & Hamilton LLP, on Wednesday, October 5, 2022 Editor's Note: Laura Harder is an Associate at Cleary Gottlieb Steen & Hamilton LLP. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Full Scope Enablement in Amgen Inc. v. [read post]
18 Aug 2022, 4:43 am by Melissa Tremblay
  Suzanne prosecuted many notable FCA cases in the government, including several qui tam cases against National Medicare Care, Inc. [read post]
1 Jul 2022, 10:02 am by Dennis Crouch
The current most-likely big case is Amgen Inc., et al. v. [read post]
16 May 2022, 12:16 pm by Dennis Crouch
Qualcomm Incorporated (licensee appellate standing) and Amgen Inc. v. [read post]
21 Apr 2022, 10:07 am by Dennis Crouch
Scope and Procedure for the Enablement Requirement: Amgen Inc., et al. v. [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
14 Apr 2022, 8:59 pm by Patent Docs
By Donald Zuhn –- Earlier today, the Federal Circuit reversed the Final Written Decision, and reconsideration of that decision, by the U.S. [read post]
2 Jan 2022, 4:38 pm by InhouseBlog
on January 13, 2022 Senior Counsel - Strategic Transactions - Mergers and Acquisitions (Remote US) at Amgen (Boston, MA) on January 13, 2022 Senior Counsel - Strategic Transactions - Mergers and Acquisitions (Remote US) at Amgen (Charlotte,... [read post]